Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Recommendation of "Buy" by Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been given a consensus recommendation of "Buy" by the five brokerages that are covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $8.63.

BIOX has been the topic of several recent analyst reports. Wall Street Zen upgraded Bioceres Crop Solutions from a "sell" rating to a "hold" rating in a research note on Saturday, June 21st. Oppenheimer decreased their price target on Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 22nd.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX traded down $0.19 during trading hours on Tuesday, hitting $4.23. 157,975 shares of the stock were exchanged, compared to its average volume of 182,645. The company's fifty day simple moving average is $4.65 and its two-hundred day simple moving average is $5.03. The company has a market cap of $265.26 million, a PE ratio of -30.21, a price-to-earnings-growth ratio of 1.27 and a beta of 0.41. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.74 and a current ratio of 1.02. Bioceres Crop Solutions has a 1-year low of $3.51 and a 1-year high of $11.78.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last issued its quarterly earnings results on Wednesday, May 21st. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.08. Bioceres Crop Solutions had a negative return on equity of 2.37% and a negative net margin of 2.14%. The company had revenue of $59.60 million for the quarter, compared to analyst estimates of $61.80 million. On average, sell-side analysts predict that Bioceres Crop Solutions will post -0.05 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Jones Financial Companies Lllp increased its stake in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after buying an additional 5,339 shares during the period. Bank of America Corp DE increased its position in Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after purchasing an additional 3,735 shares during the period. Jump Financial LLC acquired a new stake in Bioceres Crop Solutions during the 4th quarter valued at approximately $72,000. Avanza Fonder AB acquired a new stake in Bioceres Crop Solutions during the 1st quarter valued at approximately $72,000. Finally, PDT Partners LLC acquired a new stake in Bioceres Crop Solutions during the 1st quarter valued at approximately $81,000. Institutional investors and hedge funds own 17.68% of the company's stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.